blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3929190

EP3929190 - COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR MUTANT KINASE ACTIVITIES [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  06.08.2024
Database last updated on 19.10.2024
FormerExamination is in progress
Status updated on  22.06.2023
FormerRequest for examination was made
Status updated on  01.07.2022
FormerThe application has been published
Status updated on  26.11.2021
Most recent event   Tooltip13.09.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Yuhan Corporation
74 Noryangjin-ro
Dongjak-gu
Seoul 06927 / KR
[2021/52]
Inventor(s)01 / SUH, Byung-Chul
Lexington, 02420 / US
02 / SALGAONKAR, Paresh Devidas
Medford, 02155 / US
03 / LEE, Jaekyoo
North Andover, 01845 / US
04 / KOH, Jong Sung
14414 Gyeonggi-do / KR
05 / SONG, Ho-Juhn
Andover, 01810 / US
06 / LEE, In Yong
Belmont, 02478 / US
07 / LEE, Jaesang
Belmont, 02478 / US
08 / JUNG, Dong Sik
31089 Chungcheongnam-do / KR
09 / KIM, Jung-Ho
13565 Gyeonggi-do / KR
10 / KIM, Se-Won
13517 Gyeonggi-do / KR
 [2021/52]
Representative(s)Dehns
10 Old Bailey
London EC4M 7NG / GB
[N/P]
Former [2021/52]Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
Application number, filing date21171619.613.10.2015
[2021/52]
Priority number, dateUS201462063394P13.10.2014         Original published format: US 201462063394 P
[2021/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3929190
Date:29.12.2021
Language:EN
[2021/52]
Search report(s)(Supplementary) European search report - dispatched on:EP08.10.2021
ClassificationIPC:C07D403/04, A61K31/506, A61K31/4155, A61K31/167, A61P35/00
[2021/52]
CPC:
C07D403/04 (EP,CN,US); C07D403/14 (EP,CN,KR,US); A61K31/506 (KR,US);
A61P11/00 (EP); A61P25/00 (EP); A61P31/00 (EP);
A61P35/00 (EP,KR); A61P37/00 (EP,KR); A61P37/02 (EP);
A61P43/00 (EP); A61P9/00 (EP); C07D401/14 (CN);
C07D405/14 (CN); C07D409/14 (EP,CN,US); C07D413/14 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/31]
Former [2021/52]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERBINDUNGEN UND ZUSAMMENSETZUNGEN ZUR MODULATION DER KINASEAKTIVITÄTEN VON EGFR-MUTANTEN[2021/52]
English:COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR MUTANT KINASE ACTIVITIES[2021/52]
French:COMPOSÉS ET COMPOSITIONS DE MODULATION DES ACTIVITÉS DE KINASE MUTANT EGFR[2021/52]
Examination procedure28.06.2022Examination requested  [2022/31]
28.06.2022Date on which the examining division has become responsible
25.07.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
04.10.2022Amendment by applicant (claims and/or description)
21.06.2023Despatch of a communication from the examining division (Time limit: M06)
27.12.2023Reply to a communication from the examining division
07.08.2024Communication of intention to grant the patent
Parent application(s)   TooltipEP15850314.4  / EP3207035
EP19196713.2  / EP3604294
Divisional application(s)EP24166947.2  / EP4421069
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
04.10.2022Request for further processing filed
04.10.2022Full payment received (date of receipt of payment)
Request granted
17.10.2022Decision despatched
Fees paidRenewal fee
11.08.2021Renewal fee patent year 03
11.08.2021Renewal fee patent year 04
11.08.2021Renewal fee patent year 05
11.08.2021Renewal fee patent year 06
29.09.2021Renewal fee patent year 07
15.09.2022Renewal fee patent year 08
13.09.2023Renewal fee patent year 09
12.09.2024Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2010029610  (SINGH JUSWINDER [US], et al);
 [A]WO2011060295  (GENOSCO [US], et al);
 [A]WO2013014448  (ASTRAZENECA AB [SE], et al);
 [IP]WO2015025197  (JUBILANT BIOSYS LTD [IN]);
 [XP]CN104788427  (PHARMARESOURCES SHANGHAI CO LTD);
 [E]WO2015188777  (SHANGHAI FOCHON PHARMACEUTICAL CO LTD [CN]);
by applicantWO2006102642
 WO2007023105
 WO2007117465
 WO2011060295
 WO2013109882
 US8626132
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.